Evidence map›Paper›PMID 25024387›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Cowpox virus protein CPXV012 eludes CTLs by blocking ATP binding to TAP.

Rutger D Luteijn, Hanneke Hoelen, Elisabeth Kruse, Wouter F van Leeuwen, Jennine Grootens, Daniëlle Horst, Martijn Koorengevel, Jan W Drijfhout, Elisabeth Kremmer, Klaus Früh and 5 more

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Structurally diverse viral inhibitors converge on a shared mechanism to stall the antigen transporter TAP.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. A Structural Atlas of TAP Inhibition by Herpesviruses and Poxviruses.bioRxiv : the preprint server for biology · 2025
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Direct Priming of CD8Journal of virology · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Rutger D LuteijnDepartment of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
Hanneke HoelenDepartment of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
Elisabeth KruseDepartment of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
Wouter F van LeeuwenDepartment of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
Jennine GrootensDepartment of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
Daniëlle HorstDepartment of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
Martijn KoorengevelDepartment of Membrane Biochemistry and Biophysics, Utrecht University, 3584 CH Utrecht, the Netherlands;
Jan W DrijfhoutDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands;
Elisabeth KremmerHelmholtz Center Munich, German Research Center for Environmental Health, Institute of Molecular Immunology, 81377 Munich, Germany;
Klaus FrühVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006; and.
Jacques J NeefjesDepartment of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
Antoinette KillianDepartment of Membrane Biochemistry and Biophysics, Utrecht University, 3584 CH Utrecht, the Netherlands;
Robert Jan LebbinkDepartment of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
Maaike E RessingDepartment of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
Emmanuel J H J WiertzDepartment of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands; ewiertz@umcutrecht.nl.
University Medical Center Utrecht · NLUtrecht University · NLCenter for Environmental Health · USChildren's Cancer Therapy Development Institute · USLeiden University Medical Center · NLOncode Institute · NL

Funding

T Cell Control by Cowpoxvirus U19AI109948 · NIAID · WASHINGTON UNIVERSITY · PI FRUH, KLAUS J · 2014 to 2018
$6.4M
Mechanisms of T cell Escape by OrthopoxvirusesR21AI077048 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI FRUH, KLAUS J · 2007 to 2008
$419k
NIAID NIH HHS R21 AI077048NIAID NIH HHS U19 AI109948
6 · The paper itself

Abstract

CD8(+) CTLs detect virus-infected cells through recognition of virus-derived peptides presented at the cell surface by MHC class I molecules. The cowpox virus protein CPXV012 deprives the endoplasmic reticulum (ER) lumen of peptides for loading onto newly synthesized MHC class I molecules by inhibiting the transporter associated with Ag processing (TAP). This evasion strategy allows the virus to avoid detection by the immune system. In this article, we show that CPXV012, a 9-kDa type II transmembrane protein, prevents peptide transport by inhibiting ATP binding to TAP. We identified a segment within the ER-luminal domain of CPXV012 that imposes the block in peptide transport by TAP. Biophysical studies show that this domain has a strong affinity for phospholipids that are also abundant in the ER membrane. We discuss these findings in an evolutionary context and show that a frameshift deletion in the CPXV012 gene in an ancestral cowpox virus created the current form of CPXV012 that is capable of inhibiting TAP. In conclusion, our findings indicate that the ER-luminal domain of CPXV012 inserts into the ER membrane, where it interacts with TAP. CPXV012 presumably induces a conformational arrest that precludes ATP binding to TAP and, thus, activity of TAP, thereby preventing the presentation of viral peptides to CTLs.

Indexed as

Adenosine TriphosphateAntigen PresentationATP-Binding Cassette TransportersCell Line, TumorCell MembraneCowpox virusEndoplasmic ReticulumFrameshift MutationHEK293 CellsHistocompatibility Antigens Class IHumansImmune EvasionProtein BindingProtein TransportT-Lymphocytes, CytotoxicViral ProteinsAdenosine TriphosphateATP-Binding Cassette TransportersHistocompatibility Antigens Class Itransporter associated with antigen processing (TAP)Viral Proteins

Identifiers

PMID25024387
PMCPMC8354428
OpenAlexW1894965752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.